Jennifer M. Nelson
Centers for Disease Control and Prevention
43 Papers
57 Citations
Jennifer M. Nelson is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Breastfeeding & Medicine. The author has an hindex of 15, co-authored 34 publications. Previous affiliations of Jennifer M. Nelson include National Institutes of Health & United States Public Health Service.
Chat about Author
Papers
Fluoroquinolone-Resistant Campylobacter Species and the Withdrawal of Fluoroquinolones from Use in Poultry: A Public Health Success Story
TL;DR: Clinicians are likely to continue to encounter patients with fluoroquinolone-resistant Campylobacter infection and other enteric infection because of the continued circulation of fluoroquol one-time-use enrofloxacin in poultry flocks and in persons returning from foreign travel who have acquired a fluoroQO2-resistantEnteric infection while abroad.
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.
Lyudmyla Kompaniyets,Nickolas T. Agathis,Jennifer M. Nelson,Jennifer M. Nelson,Leigh Ellyn Preston,Jean Y. Ko,Jean Y. Ko,Brook Belay,Audrey F. Pennington,Melissa L. Danielson,Carla L. DeSisto,Jennifer R Chevinsky,Lyna Z. Schieber,Hussain R. Yusuf,James Baggs,William R. Mac Kenzie,William R. Mac Kenzie,Karen K. Wong,Karen K. Wong,Tegan K. Boehmer,Tegan K. Boehmer,Adi V. Gundlapalli,Alyson B. Goodman,Alyson B. Goodman +23 more
- 01 Jun 2021
TL;DR: In this paper, the authors examined the risk of severe COVID-19 illness among children associated with underlying medical conditions and medical complexity and found that the strongest risk factors for hospitalization were type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity.
Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
Amita Gupta,Jennifer M. Nelson,Timothy J. Barrett,Robert V. Tauxe,Shannon Rossiter,Cindy R. Friedman,Kevin Joyce,Kirk E. Smith,Timothy F. Jones,Marguerite A. Hawkins,Beletshachew Shiferaw,James L. Beebe,Duc J. Vugia,Terry Rabatsky-Ehr,James A. Benson,Timothy P. Root,Frederick J. Angulo +16 more
TL;DR: Ciprofloxacin resistance has emerged among Campylobacter since 1990 and has increased in prevalence since 1997, according to antimicrobial resistance surveillance data in human and chicken isolates of Campyloblacter.
310
Prolonged Diarrhea Due to Ciprofloxacin-Resistant Campylobacter Infection
Jennifer M. Nelson,Kirk E. Smith,Duc J. Vugia,Therese Rabatsky-Ehr,Suzanne Segler,Heidi D. Kassenborg,Shelley M. Zansky,Kevin Joyce,Nina Marano,Robert M. Hoekstra,Frederick J. Angulo +10 more
TL;DR: People with ciprofloxacin-resistant Campylobacter infection have a longer duration of diarrhea than do persons with c iprofloxicin-susceptible Campyloblacter infection, and additional efforts are needed to preserve the efficacy of fluoroquinolones.
168
Typhoid fever in travelers: who should be targeted for prevention?
Ellen B. Steinberg,R. Bishop,P. Haber,Amanda F. Dempsey,Robert M. Hoekstra,Jennifer M. Nelson,M. Ackers,A. Calugar,Eric D. Mintz +8 more
TL;DR: Reports of serious adverse events due to typhoid vaccination were very rare, and vaccination should be considered even for persons planning short-term travel to high-risk areas.